Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Kosmos Trio and Ejection Fraction Pivotal Study

NCT06027164 is registered in ClinicalTrials.gov with EchoNous Inc. as lead sponsor.

NCT NCT06027164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06027164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Kosmos Trio and Ejection Fraction Pivotal Study
Lead sponsor
EchoNous Inc.
Phase
Observational
Overall status
Completed
Start date
August 4, 2023
Completion date
May 16, 2024
Enrollment
153 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac disease